Form 4 Tracker
VERTEX PHARMACEUTICALS INC / MA
VRTX

86 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 25, 2026Feb 26 11:06 PMMark E. BunnageEVP, Chief Scientific Officer
Sale
620$486.35$301.5K7,284(D)

View →

Feb 25, 2026Feb 26 11:01 PMJonathan BillerEVP and Chief Legal Officer
Sale
945$486.35$459.6K13,659(D)

View →

Feb 25, 2026Feb 26 11:00 PMEdward Morrow Atkinson IIIEVP, Chief Technical Ops. Off.
Sale
668$486.35$324.9K18,432(D)

View →

Feb 25, 2026Feb 26 10:56 PMKristen AmbroseSVP & Chief Accounting Officer
Sale
223$486.35$108.5K6,981(D)

View →

Feb 25, 2026Feb 25 4:28 PMMcKechnie Duncan
Proposed Sale
4,910$487.65$2.4M

View →

Feb 25, 2026Feb 25 4:12 PMTatsis Ourania
Proposed Sale
260$486.35$126.5K

View →

Feb 25, 2026Feb 25 4:02 PMBunnage Mark E.
Proposed Sale
620$486.35$301.5K

View →

Feb 25, 2026Feb 25 3:35 PMAtkinson Edward Morrow III
Proposed Sale
668$486.35$324.9K

View →

Feb 25, 2026Feb 25 3:06 PMSachdev Amit
Proposed Sale
1,846$486.35$897.8K

View →

Feb 25, 2026Feb 25 2:41 PMBiller Jonathan
Proposed Sale
945$486.35$459.6K

View →

Feb 19, 2026Feb 23 9:21 PMAmit SachdevEVP Chief Patient & Ext Af Off
Sale
58,613$468.83$27.5M58,934(D)

View →

Feb 18, 2026Feb 19 9:28 PMOurania TatsisEVP, Chief Reg. & Quality Off.
Sale
368$473.68$174.3K48,650(D)

View →

Feb 17, 2026Feb 19 9:28 PMOurania TatsisEVP, Chief Reg. & Quality Off.
Sale
609$489.46$298.1K49,018(D)

View →

Feb 19, 2026Feb 19 9:18 PMSachdev Amit
Proposed Sale
58,613$468.83$27.5M

View →

Feb 18, 2026Feb 19 9:12 PMMark E. BunnageEVP, Chief Scientific Officer
Sale
1,182$473.68$559.9K8,486(D)

View →

Feb 17, 2026Feb 19 9:12 PMMark E. BunnageEVP, Chief Scientific Officer
Sale
2,437$489.46$1.2M9,668(D)

View →

Feb 18, 2026Feb 19 9:08 PMJonathan BillerEVP and Chief Legal Officer
Sale
1,244$473.68$589.3K15,748(D)

View →

Feb 17, 2026Feb 19 9:08 PMJonathan BillerEVP and Chief Legal Officer
Sale
2,476$489.46$1.2M16,992(D)

View →

Feb 18, 2026Feb 19 9:06 PMEdward Morrow Atkinson IIIEVP, Chief Technical Ops. Off.
Sale
817$473.68$387.0K20,727(D)

View →

Feb 17, 2026Feb 19 9:06 PMEdward Morrow Atkinson IIIEVP, Chief Technical Ops. Off.
Sale
2,031$489.46$994.1K21,544(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 1, 2026May 5 9:44 PMSuketu UpadhyayDirector
Grant/Award
3,662$424.453,595.156(D)

View →

May 1, 2026May 5 9:37 PMNancy ThornberryDirector
Grant/Award
1,831$424.45398(D)

View →

May 1, 2026May 5 9:29 PMJennifer SchneiderDirector
Grant/Award
2,229$424.45796(D)

View →

May 1, 2026May 5 9:24 PMBruce I SachsDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 9:18 PMDiana MckenzieDirector
Grant/Award
7967,787.483(D)

View →

May 1, 2026May 5 9:06 PMMichel LagardeDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 8:58 PMAlan M GarberDirector
Grant/Award
1,433$424.451,433(D)

View →

May 1, 2026May 5 8:54 PMLloyd CarneyDirector
Grant/Award
2,866$424.452,866(D)

View →

Apr 15, 2026Apr 17 8:20 PMSuketu UpadhyayDirector
Grant/Award
80.5082,799.156(D)

View →

Apr 15, 2026Apr 17 8:17 PMBruce I SachsDirector
Grant/Award
107.34515,671.866(D)

View →

Apr 15, 2026Apr 17 8:14 PMAlan M GarberDirector
Grant/Award
33.89833.898(D)

View →

Feb 19, 2026Feb 23 9:21 PMAmit SachdevEVP Chief Patient & Ext Af Off
Option Exercise
48,505$187.530(D)

View →

Jan 15, 2026Jan 20 9:48 PMSuketu UpadhyayDirector
Grant/Award
80.3162,718.648(D)

View →

Jan 15, 2026Jan 20 9:45 PMBruce I SachsDirector
Grant/Award
107.08815,564.521(D)

View →